SAGE Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 59 U.S.-traded ETFs. SAGE has around 2.9M shares in the U.S. ETF market. The largest ETF holder of SAGE is the iShares NASDAQ Biotechnology ETF (IBB), with approximately 506.67K shares. Investors may also find of interest that the ETF with the largest allocation to SAGE stock is Principal Healthcare Innovators Index ETF (BTEC), with a portfolio weight of 2.62%. On average, U.S. ETFs allocate 0.39% of SAGE to their portfolios.
Additionally, SAGE is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with SAGE as a holding is the iShares Morningstar Mid-Cap Growth ETF (JKH), with a return of 15.00%.